Reducing smoking prevalence in Australian prisons: a review of policy options.

abstract：:This article aims to define a value-based approach to pricing and reimbursement for off-patent originators using a multiple criteria decision analysis (MCDA) approach centered on a systematic analysis of current pricing and reimbursement policies in China. A drug price policy review was combined with a quantitative an...

journal_title：Applied health economics and health policy

authors： Hu S,Zhang Y,He J,Du L,Xu M,Xie C,Peng Y,Wang L

更新日期：2015-08-01 00:00:00

abstract：:Health state utility values are a major source of uncertainty in economic evaluations of interventions for age-related macular degeneration (AMD). This review identifies and critiques published utility values and methods for eliciting de novo utility values in AMD. We describe how utility values have been used in heal...

journal_title：Applied health economics and health policy

authors： Butt T,Tufail A,Rubin G

更新日期：2017-02-01 00:00:00

abstract：BACKGROUND:Limited empirical evidence exists regarding the effect of price changes on hospital behavior and, ultimately, the quality of care. Additionally, an overview of the results of prior literature is lacking. OBJECTIVE:This study aims to provide a synthesis of existing research concerning the relationship betwee...

journal_title：Applied health economics and health policy

authors： Jamalabadi S,Winter V,Schreyögg J

更新日期：2020-10-01 00:00:00

abstract：BACKGROUND:South Korea is unique in that it leads global markets in R&D as well as production of biosimilar products and was the first market into which some biosimilar products were introduced. We analyzed the time trend of market penetration and simulated saved spending by biosimilars in South Korea. METHODS:We pull...

journal_title：Applied health economics and health policy

authors： Lee HJ,Han E,Kim H

更新日期：2020-08-01 00:00:00

abstract：:This article reviews the concept of costing, and how cost data have been considered and reported in recent multinational economic evaluations. It appears that current practice frequently does not comply with microeconomic foundations and standards for good practice. A number of studies fail to indicate the year of cos...

journal_title：Applied health economics and health policy

authors： Halliday RG,Darba J

更新日期：2003-01-01 00:00:00

abstract：BACKGROUND:Cervical cancer ranks fourth amongst the commonest malignancies worldwide and the second most prevalent cancer afflicting women in low-to-middle income countries (LMICs), hence, of great public health importance. LMICs are the most affected regions as evidenced by their high prevalence of the disease. Mortal...

journal_title：Applied health economics and health policy

authors： Okeah BO,Ridyard CH

更新日期：2020-10-01 00:00:00

abstract：:The first objective of this paper is to expound the particular challenge posed by the occurrence of inconsistency in the expression of preferences by mental health patients to both economists and policy makers. Since this difficulty cannot be resolved, the second aim of the paper is to identify agents who may be count...

journal_title：Applied health economics and health policy

authors： Zweifel P

更新日期：2020-04-01 00:00:00

abstract：BACKGROUND:The management of the large patient population in Italy receiving long-term oral anticoagulation therapy (OAT) poses organizational challenges that are traditionally approached with a centralized procedure, relying on hospital-based clinics and/or GPs. However, the availability of near-patient testing device...

journal_title：Applied health economics and health policy

authors： Pradelli L,Iannazzo S,Zaniolo O,Botrugno P

更新日期：2010-01-01 00:00:00

abstract：:Memokath-051 is a thermo-expandable, nickel-titanium alloy spiral stent used to treat ureteric obstruction resulting from malignant or benign strictures. The National Institute for Health and Care Excellence (NICE) selected Memokath-051 for evaluation. The company, PNN Medical, claimed Memokath-051 has clinical superi...

journal_title：Applied health economics and health policy

authors： Eaton Turner E,Jenks M,McCool R,Marshall C,Millar L,Wood H,Peel A,Craig J,Sims AJ

更新日期：2018-08-01 00:00:00

abstract：BACKGROUND:Although the costs of treating inflammatory bowel disease (IBD) in developed countries are well established, they remain largely unknown in countries with recent histories of socio-economic transition including Serbia. OBJECTIVE:To estimate the costs of treatment including the resources used by patients wit...

journal_title：Applied health economics and health policy

authors： Kostić M,Djakovic L,Šujić R,Godman B,Janković SM

更新日期：2017-02-01 00:00:00

abstract：BACKGROUND:Hepatocellular carcinoma (HCC) is the second most common cancer in Taiwan. For males in Taiwan, it is the most dangerous cancer, with both the highest incidence and mortality rate. OBJECTIVE:To determine cancer-related medical care costs for long-term survivors of HCC. METHODS:The estimation of the lifetim...

journal_title：Applied health economics and health policy

authors： Lang HC,Wu JC,Yen SH,Lan CF,Wu SL

更新日期：2008-01-01 00:00:00

abstract：AIM:To assess the relative cost effectiveness of four strategies (academic detailing, computerised reminder systems, target payments and interactive continuing medical education) to increase the provision of screening and brief interventions by Australian GPs with the ultimate goal of decreasing risky alcohol consumpti...

journal_title：Applied health economics and health policy

authors： Shanahan M,Shakeshaft A,Mattick RP

更新日期：2006-01-01 00:00:00

abstract：INTRODUCTION:From 2000 to 2004, primary care organisations (PCOs) in England were legally required to operate a prescribing incentive scheme for their general practices. A statutory framework specified the types of target, maximum rewards and use of 'good cause for failure' provisions that schemes should include. Our o...

journal_title：Applied health economics and health policy

authors： Mason AR,Drummond MF,Hunter JA,Towse AK,Cooke J

更新日期：2005-01-01 00:00:00

abstract：OBJECTIVE:Compared to traditional drugs, specialty drugs tend to be indicated for lower prevalence diseases. Our objective was to compare the potential population health benefits associated with specialty and traditional drugs in the year following product approval. METHODS:First, we created a dataset of estimates of ...

journal_title：Applied health economics and health policy

authors： Chambers JD,Thorat T,Wilkinson CL,Salem M,Subedi P,Kamal-Bahl SJ,Neumann PJ

更新日期：2017-04-01 00:00:00

abstract：BACKGROUND:Conventional intraoperative sentinel lymph node biopsy (SLNB) in breast cancer (BC) has limitations in establishing a definitive diagnosis of metastasis intraoperatively, leading to an unnecessary second operation. The one-step nucleic amplification assay (OSNA) provides accurate intraoperative diagnosis and...

journal_title：Applied health economics and health policy

authors： Saruta Y,Puig-Junoy J

更新日期：2016-06-01 00:00:00

abstract：BACKGROUND:Immunization rates for human papillomavirus (HPV) infections remain low among teenagers despite strong evidence of the effectiveness of vaccines. Physician recommendations of the vaccine are far from universal. Several states have enacted policies that mandate HPV vaccination or distribute educational materi...

journal_title：Applied health economics and health policy

authors： Moghtaderi A,Adams S

更新日期：2016-06-01 00:00:00

abstract：:Central line-associated bloodstream infections (CLABSIs) are primary, laboratory confirmed bloodstream infections in patients with a central line within 48 h of symptom onset. Catheter-related bloodstream infection (CRBSI) is a more specific term used when the cause of infection has been confirmed by catheter tip cult...

journal_title：Applied health economics and health policy

authors： O'Connell S,Dale M,Morgan H,Carter K,Carolan-Rees G

更新日期：2020-08-05 00:00:00

abstract：:The mandatory nature of recommendations made by the National Institute for Health and Clinical Excellence (NICE) in the UK has highlighted inherent difficulties in the process of disinvestment in existing technologies to fund NICE-approved technologies. A lack of evidence on candidate technologies means that the proce...

journal_title：Applied health economics and health policy

authors： Karnon J,Carlton J,Czoski-Murray C,Smith K

更新日期：2009-01-01 00:00:00

abstract：:The biotech industry now accounts for a substantial and growing proportion of total R&D spending on new medicines. However, compared with the pharmaceutical industry, the biotech industry is financially fragile. This article illustrates the financial fragility of the biotech and pharmaceutical industries in the US and...

journal_title：Applied health economics and health policy

authors： Golec J,Vernon JA

更新日期：2009-01-01 00:00:00

abstract：BACKGROUND:Decision makers within the Calgary Health Region adopted and applied programme budgeting and marginal analysis (PBMA) for priority-setting activity across major service portfolios within the Region. METHODS:Seventeen in-depth qualitative interviews were conducted with senior managers and clinicians to gain ...

journal_title：Applied health economics and health policy

authors： Mitton C,Patten S,Donaldson C

更新日期：2004-01-01 00:00:00

abstract：BACKGROUND:Chronic obstructive pulmonary disease (COPD) affects approximately 3 million people in the UK. An 8-week pulmonary rehabilitation (PR) course is recommended under current guidelines. However, studies show that initial benefits diminish over time. OBJECTIVE:We present here an economic evaluation conducted al...

journal_title：Applied health economics and health policy

authors： Burns DK,Wilson EC,Browne P,Olive S,Clark A,Galey P,Dix E,Woodhouse H,Robinson S,Wilson A

更新日期：2016-02-01 00:00:00

abstract：BACKGROUND:As tuberculosis screening trends to targeting high-risk populations, knowing the cost effectiveness of such screening is vital to decision makers. OBJECTIVES:The purpose of this review was to compile cost-utility analyses evaluating latent tuberculosis infection (LTBI) screening in high-risk populations tha...

journal_title：Applied health economics and health policy

authors： Campbell JR,Sasitharan T,Marra F

更新日期：2015-08-01 00:00:00

abstract：BACKGROUND:European guidelines advocate the measurement of on-treatment hepatitis C virus (HCV) RNA in order to determine optimal therapy duration (response-guided therapy [RGT]) in patients with rapid virological response (RVR) or delayed virological response (DVR). Treatment response is highly dependent upon the exte...

journal_title：Applied health economics and health policy

authors： McEwan P,Kim R,Yuan Y

更新日期：2013-02-01 00:00:00

abstract：:Blockchain technology is a decentralized database that stores a registry of assets and transactions across a peer-to-peer computer network, which is secured through cryptography, and over time, its history gets locked in blocks of data that are cryptographically linked together and secured. So far, there have been use...

journal_title：Applied health economics and health policy

authors： Radanović I,Likić R

更新日期：2018-10-01 00:00:00

abstract：BACKGROUND:There is limited understanding of the health economic implications of cervical screening with human papillomavirus (HPV)-16/18 genotyping. OBJECTIVE:The aim of this study was to evaluate the cost effectiveness of cervical cancer primary screening with a HPV-16/18 genotyping test which simultaneously detects...

journal_title：Applied health economics and health policy

authors： Huh WK,Williams E,Huang J,Bramley T,Poulios N

更新日期：2015-02-01 00:00:00

abstract：BACKGROUND:This research seeks to identify the relationship between economic factors related to the ability to receive and pay for health services and adverse cancer outcomes, as well as preventative screening and behavioral factors that influence the risk of cancer. We focus on the Northern High Plains region, where w...

journal_title：Applied health economics and health policy

authors： Belasco EJ,Gong G,Pence B,Wilkes E

更新日期：2014-08-01 00:00:00

abstract：BACKGROUND:Low back pain (LBP) is a major health problem, having a substantial effect on peoples' quality of life and placing a significant economic burden on healthcare systems and, more broadly, societies. Many interventions to alleviate LBP are available but their cost effectiveness is unclear. OBJECTIVES:To identi...

journal_title：Applied health economics and health policy

authors： Andronis L,Kinghorn P,Qiao S,Whitehurst DG,Durrell S,McLeod H

更新日期：2017-04-01 00:00:00

abstract：BACKGROUND:Community-based health insurance (CBHI) schemes have been introduced in low- and middle-income countries to increase health service utilization and provide financial protection from high healthcare expenditures. OBJECTIVE:We assess the impact of household size on decisions to enroll in CBHI and demonstrate ...

journal_title：Applied health economics and health policy

authors： Ozawa S,Grewal S,Bridges JF

更新日期：2016-04-01 00:00:00

abstract：:Despite recent initiatives across a number of countries to institutionalise the use of economic evaluation in the assessment of new technologies, the evidence suggests that, to date, the impact of economic analysis on health sector decision making in practice has been low. This paper proposes that incentive compatibil...

journal_title：Applied health economics and health policy

authors： Jan S

更新日期：2003-01-01 00:00:00

abstract：BACKGROUND:Antiplatelet therapy plays a central role in the prevention of atherothrombotic events. Both acetylsalicylic acid (aspirin) and clopidogrel have been shown to reduce the risk of recurrent cardiovascular events in various subgroups of patients with vascular disease. OBJECTIVE:To estimate the cost effectivene...

journal_title：Applied health economics and health policy

authors： Logman JF,Heeg BM,Herlitz J,van Hout BA

更新日期：2010-01-01 00:00:00